Previous Close | 0.1985 |
Open | 0.2350 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.2142 - 0.4500 |
52 Week Range | 0.1380 - 15.1360 |
Volume | |
Avg. Volume | 3,556,701 |
Market Cap | 3.211M |
Beta (5Y Monthly) | 5.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -35.6400 |
Earnings Date | Nov 12, 2024 - Nov 18, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.25 |
SEATTLE, WA / ACCESSWIRE / September 18, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, ...
SEATTLE, WA / ACCESSWIRE / September 16, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, ...